A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19)
- PMID: 33641858
- PMCID: PMC7521210
- DOI: 10.1016/j.ijtb.2020.09.021
A review: Epidemiology, pathogenesis and prospect in developing vaccines for novel Coronavirus (COVID-19)
Abstract
In December 2019, a large number of coronavirus cases were emerged in Wuhan, Hubei Province, China and rapidly spread to different countries and territories around the world within four months. The World Health Organization (WHO) declared this outbreak as a global health emergency. The spread of COVID-19 over globe is highly contagious; they transmitted from person-to-person through small droplets of infected person. Many diagnosis and treatment methods have been implemented to reduce and control the outbreak. Efforts have been made to develop coronavirus vaccine against S protein or spike glycoprotein of coronavirus. COVID-19 outbreak will affect the Gross Domestic Product (GDP) of the world. At the time of preparing manuscript, total number of active cases reaches to more than 8.9 million and confirmed death reaches to approx. 4.6 lakh. This article highlights the ongoing research and advances in designing vaccine and therapeutics against COVID-19 and also focusing on the epidemiology, transmission, future direction and control the spread of infectious diseases.
Keywords: COVID-19; Convalescent plasma transfusion; Economic effect; Epidemiology; Vaccines.
Copyright © 2020 Tuberculosis Association of India. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflicts of interest The author has none to declare.
Figures



Similar articles
-
The Perspective of Coronavirus Disease Outbreak: Epidemiology, Transmission, and Possible Treatment.Vector Borne Zoonotic Dis. 2021 Feb;21(2):78-85. doi: 10.1089/vbz.2020.2678. Epub 2020 Dec 14. Vector Borne Zoonotic Dis. 2021. PMID: 33325821
-
Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective.Curr Mol Med. 2021;21(7):562-572. doi: 10.2174/1566524020666201203170230. Curr Mol Med. 2021. PMID: 33272178 Review.
-
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.Hum Vaccin Immunother. 2020 Jun 2;16(6):1232-1238. doi: 10.1080/21645515.2020.1735227. Epub 2020 Mar 18. Hum Vaccin Immunother. 2020. PMID: 32186952 Free PMC article. Review.
-
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E. J Biol Regul Homeost Agents. 2021. PMID: 33377359
-
Insights into Novel Coronavirus Disease 2019 (COVID-19): Current Understanding, Research, and Therapeutic Updates.Recent Pat Biotechnol. 2022;16(1):35-63. doi: 10.2174/1872208315666210805152122. Recent Pat Biotechnol. 2022. PMID: 34353275 Review.
References
-
- World Health Organization Section: frequently asked questions (FAQs) on coronaviruses (COVID-19) https://www.who.int/news-room/q-a-detail/q-a-coronaviruses
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical